Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8‑K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report:
May 1, 2018
(Date of earliest event reported)

DIGIRAD CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
 
001-35947
 
33-0145723
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)

1048 Industrial Court,
Suwanee, GA 30024
(Address of principal executive offices, including zip code)

(858) 726-1600
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§232.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
o
 
 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 2.02.  Results of Operations and Financial Condition

On May 1, 2018, Digirad Corporation issued a press release announcing financial results for the three months ended March 31, 2018. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01.  Financial Statements and Exhibits
 
(a) Financial statements:
None
(b) Pro forma financial information:
None
(c) Shell company transactions:
None
(d)  Exhibits:
99.1 Press Release of Digirad Corporation dated May 1, 2018
99.2 Information Related to the Use of Non-GAAP Financial Measures    

  





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
DIGIRAD CORPORATION
 
 
 
 
By:
/s/ MATTHEW G. MOLCHAN
 
 
 
Matthew G. Molchan
President, Chief Executive Officer and Interim Chief Financial Officer
(Principal Executive Officer and Financial Officer)


Date:     May 1, 2018




Exhibit Index

Exhibit No.
 
Description
 
 
 
 
Press Release of Digirad Corporation dated May 1, 2018

 
Information Related to the Use of Non-GAAP Financial Measures


Exhibit


Exhibit 99.1
News Release
For immediate release
For more information contact:
May 1, 2018
Matthew G. Molchan
 
Chief Executive Officer
 
858-726-1600
 
ir@digirad.com

Digirad Corporation Reports Financial Results for the
First Quarter Ended March 31, 2018

Debt paydown of $6.5 million during the quarter
Announces 2018 financial guidance
Company to pay regular quarterly cash dividend of $0.055 cents per share


Suwanee, GA. - May 1, 2018 - Digirad Corporation (Nasdaq: DRAD) today reported its financial results for the first quarter ended March 31, 2018.
Total revenues from continuing operations for the first quarter were $25.5 million, compared to $25.8 million in the first quarter of the prior year.
Net loss from continuing operations for the first quarter was $1.4 million, or $0.07 net loss per diluted share from continuing operations, compared to net loss of $2.3 million, or $0.11 net loss per diluted share in the same period in the prior year. Non-GAAP adjusted net loss from continuing operations for the first quarter was $1.4 million, or $0.07 adjusted net loss from continuing operations per diluted share, compared to $1.3 million, or $0.06 adjusted net loss per diluted share in the same period in the prior year.
Non-GAAP adjusted EBITDA from continuing operations for the first quarter was $1.0 million, compared to $1.1 million in the same period in the prior year.
Digirad President and CEO Matt Molchan said, “Overall, our business performed within our expectations. Despite some harsh weather conditions in the Midwest and the Northeast, our service businesses, Diagnostic Services and Mobile Healthcare, continued to deliver convenient, effective and efficient healthcare solutions on an as needed, when needed, and where needed basis across the country during the quarter." Molchan continued, “Our Diagnostic Imaging business continued to see improvements, exceeding revenue for the quarter on a year over year basis. Also, in the quarter, as previously announced - we sold our service contracts in our MDSS business unit to Philips - effectively discontinuing operations in this unit. We also completed some operational and personnel changes in our core business areas as a result of the divestiture of the MDSS business. Finally, we were able to pay down our debt from $19.5 million at the beginning of the quarter to $13.0 million at the end of the quarter. We expect our business to continue to generate free cash flow, which we will use to pay down debt and fund our ongoing dividend, both of which we believe deliver value to our shareholders.”
The Company also announces a cash dividend of $0.055 cents per share that will be paid on May 30, 2018, to shareholders of record on May 15, 2018.
2018 Financial Guidance
The Company announced its financial guidance for 2018, which is to generate revenues from continuing operations of between $100 and $105 million, non-GAAP adjusted EBITDA of between $8.5 and $9.5 million, and free cash flow between $4 and $5 million.
Conference Call Information
A conference call is scheduled for 11:00 a.m. EDT on May 1, 2018 to discuss the results and management's outlook. The call may be accessed by dialing 1-877-407-9039 (international callers: +1-201-689-8470) five minutes prior to the scheduled start time and referencing Digirad. A simultaneous webcast of the call may be accessed online from the Events & Presentations link on the





Investor Relations page at http://drad.client.shareholder.com; an archived replay of the webcast will be available within 15 minutes of the end of the conference call.
Use of Non-GAAP Financial Measures by Digirad Corporation
This Digirad news release presents the non-GAAP financial measures “adjusted net income(loss),” “adjusted net income(loss) per diluted share,” “free cash flow”, and “adjusted EBITDA.” The most directly comparable measure for these non-GAAP financial measures are net income and diluted net income per share. The Company has included below unaudited adjusted financial information, which presents the Company's results of operations after excluding acquired intangible asset amortization, acquisition related contingent consideration adjustments, unrealized gain(loss) on available-for-sale securities, and non-recurring related income tax adjustments. Further excluded in the measure of adjusted EBITDA are interest, taxes, depreciation, amortization and stock-based compensation.

A discussion of the reasons why management believes that the presentation of non-GAAP financial measures provides useful information to investors regarding Digirad's financial condition and results of operations is included as Exhibit 99.2 to Digirad's report on Form 8-K filed with the Securities and Exchange Commission on May 1st, 2018.
About Digirad Corporation
Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis. Digirad’s diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers through the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. For more information, please visit www.digirad.com.
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. Some of these forward-looking statements can be identified by the use of forward-looking words such as “believes,” “expects,” “may,” “will,” “should,” “seek,” “approximately,” “intends,” “plans,” “estimates,” or “anticipates,” or the negative of those words or other comparable terminology, or in specific statements such as the Company's ability to deliver value to customers, the ability to grow and generate positive cash flow, the ability to execute on restructuring activities, and ability to successfully execute acquisitions. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. These risks are detailed in Digirad's filings with the U.S. Securities and Exchange Commission, including the Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports. Readers are cautioned to not place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Digirad undertakes no obligation to revise or update the forward-looking statements contained herein.






(Financial tables follow)






Digirad Corporation
Consolidated Statements of Operations
(Unaudited)
 
Three Months Ended
 
March 31,
(in thousands, except per share amounts)
2018
 
2017
Revenues
 
 
 
Services
$
22,623

 
$
23,057

Product and product-related
2,842

 
2,783

Total revenues
25,465

 
25,840

Cost of revenues:
 
 
 
Services
19,261

 
18,583

Product and product-related
1,597

 
1,655

Total cost of revenues
20,858

 
20,238

 
 
 
 
Gross profit
4,607

 
5,602

Total gross profit percentage
18.1
%
 
21.7
%
Services gross profit percentage
14.9
%
 
19.4
%
Product and product-related gross profit percentage
43.8
%
 
40.5
%
 
 
 
 
Operating expenses:
 
 
 
Marketing and sales
1,467

 
1,783

General and administrative
4,392

 
4,896

Amortization of intangible assets
357

 
374

Total operating expenses
6,216

 
7,053

 
 
 
 
Loss income from operations
(1,609
)
 
(1,451
)
 
 
 
 
Other expense:
 
 
 
Other expense, net
(17
)
 

Interest expense, net
(217
)
 
(193
)
Total other expense
(234
)
 
(193
)
 
 
 
 
Loss from continuing operations before income taxes
(1,843
)
 
(1,644
)
Income tax benefit (expense)
455

 
(607
)
Net loss from continuing operations
(1,388
)
 
(2,251
)
Income from discontinued operations
5,494

 
175

Net income (loss)
$
4,106

 
$
(2,076
)
 
 
 
 
Net income (loss) per share - basic and diluted
 
 
 
  Continuing operations
$
(0.07
)
 
$
(0.11
)
  Discontinued operations
$
0.27

 
$
0.01

Net income (loss) per share - basic and diluted
$
0.20

 
$
(0.10
)
Dividends declared per common share
$
0.055

 
$
0.05

 
 
 
 
Weighted average shares outstanding – basic and diluted
20,092

 
19,933






Digirad Corporation
Consolidated Balance Sheets
(Unaudited)
(in thousands, except share data)
March 31,
2018
 
December 31,
2017
Assets:
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
1,033

 
$
1,877

Securities available-for-sale
116

 
97

Accounts receivable, net
12,752

 
15,887

Inventories, net
5,755

 
5,501

Restricted cash
243

 
242

Other current assets
2,287

 
1,972

 Total current assets
22,186

 
25,576

Property and equipment, net
27,176

 
28,365

Intangible assets, net
7,473

 
7,830

Goodwill
2,392

 
2,392

Restricted cash
101

 
101

Non-current assets held for sale

 
1,736

Other assets
634

 
703

Total assets
$
59,962

 
$
66,703

 
 
 
 
Liabilities:
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
5,712

 
$
5,207

Accrued compensation
3,208

 
5,507

Accrued warranty
182

 
204

Deferred revenue
1,922

 
2,302

Current liabilities held for sale

 
835

Other current liabilities
2,666

 
2,915

Total current liabilities
13,690

 
16,970

Long-term debt
13,001

 
19,500

Deferred tax liabilities
361

 
254

Other liabilities
1,979

 
2,180

Total liabilities
29,031

 
38,904

 
 
 
 
Stockholders’ equity:
 
 
 
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued or outstanding

 

Common stock, $0.0001 par value: 80,000,000 shares authorized; 20,118,336 and 20,060,311 shares issued and outstanding (net of treasury shares) at March 31, 2018 and December 31, 2017, respectively
2

 
2

Treasury stock, at cost; 2,588,484 shares at March 31, 2018 and December 31, 2017
(5,728
)
 
(5,728
)
Additional paid-in capital
147,189

 
148,163

Accumulated other comprehensive loss
(22
)
 
(5
)
Accumulated deficit
(110,510
)
 
(114,633
)
Total stockholders’ equity
30,931

 
27,799

Total liabilities and stockholders’ equity
$
59,962

 
$
66,703






Digirad Corporation
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
 
 
 
Three Months Ended March 31,
 
(in thousands, except per share amounts)
 
2018
 
2017
 
 
 
 
 
 
 
 
Net loss from continuing operations
 
$
(1,388
)
 
$
(2,251
)
 
 
Acquired intangible amortization
 
357

 
374

 
 
Acquisition related contingent consideration valuation adjustment (1)
 

 
(57
)
 
 
Unrealized loss on available-for-sale securities (2)
 
17

 

 
 
Restructuring costs (3)
 
97

 

 
 
Income tax items (4)
 
(455
)
 
607

 
Non-GAAP adjusted net loss from continuing operations
 
$
(1,372
)
 
$
(1,327
)
 
 
 
 
 
 
 
 
Net loss per diluted share from continuing operations (5)
 
$
(0.07
)
 
$
(0.11
)
 
 
Acquired intangible amortization
 
0.02

 
0.02

 
 
Unrealized loss on available-for-sale securities (2)
 

 

 
 
Acquisition related contingent consideration valuation adjustment (1)
 

 

 
 
Restructuring costs (3)
 

 

 
 
Income tax items (4)
 
(0.02
)
 
0.03

 
Non-GAAP adjusted net loss per diluted share from continuing operations (5)
 
$
(0.07
)
 
$
(0.06
)
 
 
 
 
 
 
 
 

 
 
 
Three Months Ended March 31,
 
(in thousands)
 
2018
 
2017
 
 
 
 
 
 
 
 
Net loss from continuing operations
 
$
(1,388
)
 
$
(2,251
)
 
 
Acquisition related contingent consideration valuation adjustment (1)
 

 
(57
)
 
 
Unrealized loss on available-for-sale securities (2)
 
17

 

 
 
Restructuring costs (3)
 
97

 

 
 
Depreciation and amortization
 
2,265

 
2,366

 
 
Stock-based compensation
 
201

 
255

 
 
Interest expense, net
 
217

 
193

 
 
Income tax expense (benefit)
 
(455
)
 
607

 
Non-GAAP adjusted EBITDA from continuing operations
 
$
954

 
$
1,113

 
 
 
 
 
 
 
 
(1) Reflects fair value adjustment to estimate of contingent consideration related to acquisitions.
(2) Reflects change in fair value on equity investments classified as available-for-sale.
(3) Reflects severance related costs.
(4) The Company has a significant tax NOL that is offset by a full valuation allowance recorded in the fourth quarter of 2017 in the GAAP consolidated financial statements. As a result, for purposes of non-GAAP measures, we utilized a 0% effective tax rate. 
(5) Per share amounts are computed independently for each discrete item presented. Therefore, the sum of the quarterly per share amounts will not necessarily equal to the total for the year, and sum of individual items may not equal the total.














Digirad Corporation
Reconciliation of Operating Cash Flow to Free Cash Flow
(Unaudited)
 
Three Months Ended March 31,
(in thousands)
2018
 
2017
Net cash provided by operating activities
$
420

 
$
1,924

Purchases of property and equipment, net of dispositions
(161
)
 
(485
)
Free cash flow
$
259

 
$
1,439


Digirad Corporation
Supplemental Debt Information
(Unaudited)

The following table reflects outstanding principal balances and interest rates for the Company's debt at March 31, 2018 and December 31, 2017:
 
March 31, 2018
 
December 31, 2017
(in thousands)
Balance
Interest Rate
 
Balance
Interest Rate
Revolving Credit Facility (1)
$
13,001

4.25%
 
$
19,500

3.90%
Total borrowings
$
13,001

 
 
$
19,500

 
 
(1) A Revolving Credit Agreement was entered into with Comerica Bank on June 21, 2017. The agreement consists of a revolving credit facility with a five-year term, maturing on June 21, 2022.

Digirad Corporation
Supplemental Segment Information
(Unaudited)
 
Three Months Ended March 31,
(in thousands)
2018
 
2017 (1)
Revenue by segment:
 
 
 
Diagnostic Services
$
12,025

 
$
12,202

Diagnostic Imaging
2,842

 
2,783

Mobile Healthcare
10,598

 
10,855

Condensed consolidated revenue
$
25,465

 
$
25,840

Gross profit by segment:
 
 
 
Diagnostic Services
$
2,247

 
$
2,836

Diagnostic Imaging
1,245

 
1,128

Mobile Healthcare
1,115

 
1,638

Condensed consolidated gross profit
$
4,607

 
$
5,602

Income (loss) from continuing operations by segment:
 
 
 
Diagnostic Services
$
(290
)
 
$
16

Diagnostic Imaging
(204
)
 
(437
)
Mobile Healthcare
(1,115
)
 
(1,030
)
Condensed consolidated loss from continuing operations
$
(1,609
)
 
$
(1,451
)





(1) Segment information has been recast for all periods presented to reflect the MDSS disposition as discontinued operations. As certain shared function costs previously allocated to MDSS are not allocable to discontinued operations, prior period corporate costs have been re-allocated amongst the continuing reportable segments.


Exhibit


Exhibit 99.2

Use of Non-GAAP Financial Measures

In addition to financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), information containing non-GAAP financial measures for Digirad Corporation (the “Company”) was disclosed in the Company's press release (the “Press Release”) dated May 1, 2018 announcing results for the three months ended March 31, 2018 that accompanied a conference call held by the Company on May 1, 2018. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures. Management encourages readers to rely upon the GAAP numbers, but includes the non-GAAP financial measures as supplemental metrics to assist readers. Definitions of the non-GAAP financial measures are included in the Press Release.
In the Press Release, the Company presented the non-GAAP financial measures “adjusted net income (loss),” “adjusted net income (loss) per diluted share,” “adjusted EBITDA,” and "free cash flow." Company management uses these non-GAAP financial measures to evaluate the Company's performance. As the Company's core business is providing healthcare services and products to the healthcare industry, Company management finds it useful to use financial measures that do not include acquired intangible asset amortization, acquisition related contingent consideration adjustments, unrealized gain(loss) on available-for-sale securities, and non-recurring related income tax adjustments. While we may have these types of items and charges in the future, Company management believes that they are not reflective of the day-to-day offering of its products and services and relate more to strategic, multi-year corporate actions, without predictable trends, and that may obscure the trends and financial performance of the Company's core business. In the case of “adjusted EBITDA,” Company management believes the exclusion of interest, taxes, depreciation, amortization, and stock-based compensation is a very common measure utilized in the investment community and it helps Company management benchmark its operations and results with the industry.
The limitation associated with using these non-GAAP financial measures is that these measures exclude items that impact the Company's current period operating results. This limitation is best addressed by using these non-GAAP financial measures in combination with “net income (loss),” “net income (loss) per diluted share,” and "operating cash flow" (the most comparable GAAP measures) because these non-GAAP financial measures do not reflect items that impact current period operating results and may be higher or lower than the most comparable GAAP measure.